The usefulness of γ-glutamyltransferase as a marker of cardiovascular function in africans and caucasians: The SABPA study

Clinical and Experimental Hypertension

Volumn 34, Issue 1, 2012, Pages 8-16

  Huisman, Hugo Willem ^a   Schutte, Rudolph ^a   Schutte, Aletta Elisabeth ^a   Van Rooyen, Johannes Marthinus ^a   Malan, Nicolaas Theodore ^a   Fourie, Carla Maria Theresia ^a   Glyn, Matthew Colin ^a   Malan, Leone ^a  

^a NORTH WEST UNIVERSITY   (South Africa)

Author keywords

glutamyltransferase; Cardiovascular diseases; Ethnic; Gender; Vascular dysfunction

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CHOLESTEROL; GAMMA GLUTAMYLTRANSFERASE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; REACTIVE OXYGEN METABOLITE; TRIACYLGLYCEROL;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTERIAL WALL THICKNESS; ARTICLE; CARDIOVASCULAR FUNCTION; CAROTID ARTERY; CAUCASIAN; DIASTOLIC BLOOD PRESSURE; ETHNIC DIFFERENCE; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; MALE; NEGRO; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CARDIOVASCULAR PHYSIOLOGICAL PHENOMENA; CROSS-SECTIONAL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; MALE; MIDDLE AGED; REGRESSION ANALYSIS; SEX DISTRIBUTION; SOUTH AFRICA;

EID: 84856653582     PISSN: 10641963     EISSN: 15256006     Source Type: Journal    
DOI: 10.3109/10641963.2011.628727     Document Type: Article

References (42)

1. Vorster HH. The emergence of cardiovascular disease during urbanization of Africans. Public Health Nutr 2002; 5: 239-243. (Pubitemid 41128313)
2. van Rooyen JM, Kruger HS, Huisman HW et al. An epi-demiological study of hypertension and its determinants in a population in transition: the THUSA study. J Hum Hypertens 2000; 14:779-787. (Pubitemid 32015829)
3. Huisman HW, van Rooyen JM, Malan NT et al. Prolactin, testosterone and cortisol as possible markers of changes in cardiovascular function associated with urbanization. J Hum Hypertens 2002; 16:829-835. (Pubitemid 36118907)
4. Sliwa K, Wilkinson D, Ntyintyane L et al. Spectrum of heart disease and risk factors in a black urban population in South Africa (the Heart of Soweto Study): a cohort study. Lancet 2008; 371:915-922. (Pubitemid 351375275)
5. Simao ANC, Dichi JB, Barbosa DS, Cecchini R, Dichi I. Influence of uric acid and glutamyltransferase on total antiox-idant capacity and oxidative stress in patients with metabolic syndrome. Nutrition 2008; 24:675-681.
6. Wannamethee SG, Lennon L, Shaper AG. The value of gamma- glutamyltransferase in cardiovascular risk prediction in men without diagnosed cardiovascular disease or diabetes. Atherosclerosis 2008; 201:168-175.
7. Turgut O, Yilmaz MB, Yalta K, Tandogan I. Gamma-glutamyltransferase as a useful predictor for cardiovascular risk: clinical and epidemiological perspectives. Atherosclerosis 2009; 202:348-349.
8. Turgut O, Yilmaz A, Yalta K, Karadas F, Yilmaz MB. γ- Glutamyltransferase is a promising biomarker for cardiovascular risk. Med Hypotheses 2006; 67:1060-1064. (Pubitemid 44302237)
9. Lim JS, Yang JH, Chun BY et al. Is serum γ-glutamyltransferase inversely associated with serum antiox-idants as a marker of oxidative stress? Free Radic Biol Med 2004; 37:1018-1023.
10. Song SH, Kwak IS, Kim YJ et al. Can γ-glutamyltransferase be an additional marker of arterial stiffness? Circ J 2007; 71:1715-1720.
11. Shankar A, Li J, Klein BEK, Nieto FJ, Klein R. Serum gamma- glutamyltransferase level and peripheral arterial disease. Atherosclerosis 2008; 199:102-109. (Pubitemid 351902197)
12. Saijo Y, Utsugi M, Yoshioka E et al. The relationship of gamma-glutamyltransferase to C-reactive protein and arterial stiffness. Nutr Metab Cardiovasc Dis 2008; 18:211-219. (Pubitemid 351374796)
13. Mason JE, Starke RD, Kirk van JE. Gamma-glutamyl trans-ferase: a novel cardiovascular risk biomarker. Prev Cardiol 2010; 13:36-41.
14. Acikgoz N, Ermis N, Yagmur J et al. Elevated oxida-tive stress markers and its relationship with endothe-lial dysfunction in Behcet disease. Angiology 2010, doi: 10.1177/0003319710382417.
15. Kanbay A, Kaya E, Buyukoglan H et al. Serum gamma-glutamyltransferase activity is an independent predictor for cardiovascular disease in obstructive sleep apnea syndrome. Respir Med 2010, doi: 10.1016/j.med.2010.12.003.
16. Xu Y, Bi YF, Xu M et al. The cross-sectional and longitudinal association of serum alanine aminotransaminase and gamma glutamyltransferase with metabolic syndrome in middle-aged and elderly Chinese. J Diabetes 2010, doi: 10.1111/j.1753-0407.2010.00111.
17. Dahlof B, Devereux RB, Julius S et al. Characteristics of 9194 patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention for Endpoint Reduction in Hypertension. Hypertension 1998; 32(6):989-997. (Pubitemid 29001425)
18. Julius S, Alderman MH, Beevers G, et al. Cardiovascular risk reduction in hypertensive black patients with left ventricular hypertrophy: the LIFE study. J Am Coll Cardiol 2004; 43(6):1047-1055. (Pubitemid 38352987)
19. Okin PM, Roman MJ, Devereux RB, Kligfield P. Electrocar-diographic identification of increased left ventricular mass by simple voltage-duration products. J Am Coll Cardiol 1995; 25(2):417-423.
20. Touboul PJ, Hennerici MG, Meairs S et al. Mannheim carotid intima-media thickness consensus (2004-2006). An update on behalf of the Advisory Board of the 3rd and 4th Watching the Risk Symposium, 13th and 15th European Stroke Conferences, Mannheim, Germany, 2004, and Brussels, Belgium, 2006. Cerebrovasc Dis 2007; 23:75-80. (Pubitemid 46112808)
21. Liang Q, Wendelhag I, Wikstrand J, Gustavsson T. A multi-scale dynamic programming procedure for boundary detection in ultrasonic artery images. IEEE Trans Med Imaging 2000; 19:127-142. (Pubitemid 30594808)
22. Wendelhag I, Liang Q, Gustavsson T, Wikstrand J. A new automated computerized analyzing system simplifies readings and reduces the variability in ultrasound measurement of intima-media thickness. Stroke 1997; 28:2195-2200. (Pubitemid 27497922)
23. Mancia G, De BG, Dominiczak A et al. 2007 Guidelines for the management of arterial hypertension. J Hypertens 2007; 25:1105-1187.
24. International Society for the Advancement of Kinanthro-pometry (ISAK). International Standards for Anthropometric Assessment. Adelaide: National library of Australia, 2001.
25. Hayashi I, Morishita Y, Imai K et al. High-throughput spec-trophotometric assay of reactive oxygen species in serum. Mutat Res Genet Toxicol Environ Mutagen 2007; 631:55-61. (Pubitemid 46809621)
26. Ren J, Pang ZC, Gao WG, et al. C-reactive protein and gamma-glutamyltransferase concentrations in relation to the prevalence of type 2 diabetes diagnosed by glucose or HbA1c criteria in Chinese adults in Qingdao, China. Exp Diabetes Res 2010, doi: 10.1155/2010/761715.
27. Akehi Y, Tsutsumi Y, Tatsumoto A et al. Serum γ- glutamyltransferase, triglyceride and total cholesterol are possible prediabetic risk markers in young Japanese men. Endocr J 2010; 57(11):981-989.
28. Montonen J, Drogan D, Joost HG et al. Estimation of the contribution of biomarkers of different metabolic pathways to risk of type 2 diabetes. Eur J Epidemiol 2011; 26(1):29-38.
29. Conen D, Vollenweider P, Rousson V et al. Use of a Mendelian randomization approach to assess the causal relation of gamma- glutamyltransferase with blood pressure and serum insulin levels. Am J Epidemiol 2010; 172(12):1431-1441.
30. Yagmur J, Ermis N, Acikgoz N et al. Elevated serum gamma-glutamyl transferase activity in patients with cardiac syndrome X and its relationship with carotid intima media thickness. Acta Cardiol 2010; 65(5):515-519.
31. Eroglu S, Sade LE, Polat E et al. Association between serum gamma-glutamyltransferase activity and carotid intima-media thickness. Angiology 2011; 62(2):107-110.
32. Pompella A, Emdin M, Paolicchi A, Franzini M. Serum gamma- glutamyltransferase and intima-media thickness: pointing again to wall/lumen interactions in atherosclerosis. Angiol-ogy 2011; 62(2):105-106.
33. Li M, Campbell S, McDermott R. Gamma-glutamyltransferase, obesity, physical activity, and the metabolic syndrome in indigenous Australian adults. Obesity 2010, doi: 10.1038/oby.2008.617.
34. Schutte AE, Schutte R, Huisman HW et al. Classifying Africans with the metabolic syndrome. Horm Metab Res 2009; 41:79-85.
35. Schutte AE, Olckers A. Metabolic syndrome risk in black South African women compared to Caucasian women. Horm Metab Res 2007; 39:651-657. (Pubitemid 47492648)
36. Walker AR, Walker BF, Walker AJ, Vorster HH. Low frequency of adverse sequelae of obesity in South African rural black women. Int J Vitam Nutr Res 1989; 59:224-228. (Pubitemid 19161563)
37. Sobngwi E, Mauvais-Jarvis F, Vexiau P, Mbanya JC, Gautier JF. Diabetes in Africans. Part 1: epidemiology and clinical specificities. Diabetes Metab 2001; 27: 628-634. (Pubitemid 34007857)
38. Schutte AE, Huisman HW, van Rooyen JM et al. Should obesity be blamed for the high prevalence rates of hypertension in black South African women? J Hum Hypertens 2008; 22:528-536.
39. Bau PFD, Claiton HD, Rosito GA, Manfroi WC, Fuchs FD. Alcohol consumption, cardiovascular health, and endothelial function markers. Alcohol 2007; 41:479-488. (Pubitemid 350016709)
40. Otsuki M, Kasayama S, Saito H, Mukai M, Koga M. Sex differences of age-dependent changes of insulin sensitivity in Japanese nondiabetic subjects. Diabetes Care 2005; 28:2590-2591. (Pubitemid 41384324)
41. Misra A, Vikram NK. Clinical and pathophysiological consequences of abdominal adiposity and abdominal adipose tissue depots. Nutrition 2003; 19:457-466. (Pubitemid 36452353)
42. Paolicchi A, Emdin M, Ghliozeni E. Human atherosclerotic plaques contain gamma-glutamyl transpeptidase enzyme activity. Circulation 2004; 109:1440. (Pubitemid 38387833)